Westwell Demonstrates How AI-Powered Autonomous Freight Is Transforming Border Logistics
HONG KONG, June 25, 2026 /PRNewswire/ -- As cross-border trade volumes continue to grow, border crossings are evolving beyond traditional transit points into increasingly important logistics hubs. Improving freight throughput, operational efficiency...
LEOTEK Demonstrates Physical AI for Safer and Smarter Roadways at ITS America 2026
Interlux AI-Powered Traffic Infrastructure Transforms Intersections into Intelligent Sensing Nodes for Real-Time Mobility and Safety Applications SAN JOSE, Calif., June 12, 2026 /PRNewswire/ -- At ITS America 2026, LEOTEK showcased how Physical AI...
Coachella Takes the Crown: U.S. Festivals Dominate the Inaugural 'Global Festival Attractiveness Index' ('Yanolja Festival Index')
Yanolja Research Unveils Data-Driven Rankings, Showcasing the Overwhelming Power of American Cultural Events SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Yanolja Research, a global research institute specializing in the travel and tourism...
AIDIMM™ & AILPBGA™ Make Global Debut | Longsys Spotlights Full-Stack Edge AI Storage Solutions at COMPUTEX 2026
TAIPEI, June 4, 2026 /PRNewswire/ -- From June 2 to 5, 2026, COMPUTEX 2026 in Taipei runs under the theme "AI Together," focusing on AI computing and next-gen technologies. Longsys (301308.SZ), under its own theme "Edge AI Storage • Integrated...
Origin Agritech Co-Authors Plant Biotechnology Journal Study That Breaks the Long-Standing Trade-Off Between Early-Maturing and High-Yield Corn
Gene-Editing Strategy Targets the Regulatory Switches of a Key Corn Gene, Producing Corn That Flowers Up to Five Days Earlier With Yields Comparable to Standard Varieties — A Foundation for Origin's Next-Generation Hybrid Pipeline BEIJING, June 2,...
High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing...
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
CHICAGO, May 31, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the Company's first-in-class PD-1/VEGF bispecific antibody, has achieved a statistically significant and clinically meaningful...
TERREPOWER Demonstrates Decarbonization and Resource Efficiency at Scale in 2025 Corporate Sustainability Report
DAPHNE, Ala., May 19, 2026 /PRNewswire/ -- TERREPOWER, formerly BBB Industries, a pure‑play aftermarket leader in sustainable manufacturing, today released its 2025 Corporate Social Responsibility Report detailing measurable progress in emissions...
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application...
19.3% Weight Reduction, 16.5 cm Waist Circumference Decrease, SBP/DBP Reductions of 22.9/12.9 mmHg, 70.7 μmol/L Uric Acid Reduction, and 33.6% Triglyceride Reduction: BGM0504 Demonstrates Comprehensive Cardiometabolic Regulation Capabilities
SUZHOU, China, May 7, 2026 /PRNewswire/ -- Recently, BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as "BrightGene Bio-Medical " or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP...